Pro Medicus Gelecekteki Büyüme
Future kriter kontrolleri 4/6
Pro Medicus kazanç ve gelirin sırasıyla yıllık 19.1% ve 17.1% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 19.1% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 47.8% olacağı tahmin edilmektedir.
Anahtar bilgiler
19.1%
Kazanç büyüme oranı
19.1%
EPS büyüme oranı
| Healthcare Services kazanç büyümesi | 20.7% |
| Gelir büyüme oranı | 17.1% |
| Gelecekteki özkaynak getirisi | 47.8% |
| Analist kapsamı | Good |
| Son güncelleme | 18 Nov 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Shareholders Will Probably Hold Off On Increasing Pro Medicus Limited's (ASX:PME) CEO Compensation For The Time Being
Nov 18
With EPS Growth And More, Pro Medicus (ASX:PME) Makes An Interesting Case
Nov 11Do Pro Medicus' (ASX:PME) Earnings Warrant Your Attention?
May 02Here's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention Today
Jan 15Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Dec 10Here's Why Pro Medicus (ASX:PME) Has Caught The Eye Of Investors
Oct 09Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention
Aug 12Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Jul 08Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)
May 09Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
Apr 02Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital
Jan 25We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease
Dec 13Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)
Oct 26Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Sep 14Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Jul 06Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Jun 15Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?
Mar 16Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Feb 23Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
Oct 26Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively
Aug 13Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?
Jul 26Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency
May 07Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Mar 15This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)
Feb 20Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Feb 18
Is Pro Medicus (ASX:PME) The Next Multi-Bagger?
Feb 01How Much Did Pro Medicus' (ASX:PME) CEO Pocket Last Year?
Jan 12Should You Be Adding Pro Medicus (ASX:PME) To Your Watchlist Today?
Dec 28Pro Medicus (ASX:PME) Has Rewarded Shareholders With An Exceptional 825% Total Return On Their Investment
Dec 11Is Pro Medicus Limited's (ASX:PME) Shareholder Ownership Skewed Towards Insiders?
Nov 26Pro Medicus's (ASX:PME) Earnings Are Growing But Is There More To The Story?
Aug 09What Kind Of Shareholders Hold The Majority In Pro Medicus Limited's (ASX:PME) Shares?
Aug 09Does Pro Medicus (ASX:PME) Have The DNA Of A Multi-Bagger?
Jul 21How Much Are Pro Medicus Limited (ASX:PME) Insiders Taking Off The Table?
Jul 03Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 6/30/2027 | 316 | 174 | 158 | 167 | 12 |
| 6/30/2026 | 258 | 138 | 129 | 136 | 12 |
| 6/30/2025 | 210 | 109 | 102 | 107 | 12 |
| 6/30/2024 | 162 | 83 | 75 | 82 | N/A |
| 3/31/2024 | 152 | 76 | 70 | 77 | N/A |
| 12/31/2023 | 142 | 70 | 65 | 71 | N/A |
| 9/30/2023 | 134 | 65 | 60 | 67 | N/A |
| 6/30/2023 | 125 | 61 | 56 | 63 | N/A |
| 3/31/2023 | 115 | 56 | 51 | 59 | N/A |
| 12/31/2022 | 106 | 51 | 47 | 55 | N/A |
| 9/30/2022 | 100 | 48 | 50 | 58 | N/A |
| 6/30/2022 | 93 | 44 | 53 | 62 | N/A |
| 3/31/2022 | 87 | 41 | 47 | 55 | N/A |
| 12/31/2021 | 81 | 38 | 41 | 49 | N/A |
| 9/30/2021 | 74 | 34 | 36 | 44 | N/A |
| 6/30/2021 | 68 | 31 | 31 | 39 | N/A |
| 3/31/2021 | 64 | 28 | 27 | 36 | N/A |
| 12/31/2020 | 59 | 25 | 24 | 32 | N/A |
| 9/30/2020 | 58 | 24 | 24 | 32 | N/A |
| 6/30/2020 | 57 | 23 | 24 | 31 | N/A |
| 3/31/2020 | 55 | 23 | 25 | 33 | N/A |
| 12/31/2019 | 54 | 22 | 27 | 34 | N/A |
| 9/30/2019 | 52 | 21 | 22 | 30 | N/A |
| 6/30/2019 | 50 | 19 | 17 | 25 | N/A |
| 3/31/2019 | 47 | 17 | N/A | N/A | N/A |
| 12/31/2018 | 43 | 16 | 7 | 14 | N/A |
| 9/30/2018 | 39 | 13 | 7 | 14 | N/A |
| 6/30/2018 | 34 | 10 | 7 | 14 | N/A |
| 3/31/2018 | 33 | 9 | N/A | N/A | N/A |
| 12/31/2017 | 32 | 8 | N/A | 15 | N/A |
| 9/30/2017 | 32 | 9 | N/A | 15 | N/A |
| 6/30/2017 | 32 | 9 | N/A | 15 | N/A |
| 3/31/2017 | 30 | 9 | N/A | 13 | N/A |
| 12/31/2016 | 28 | 8 | N/A | 12 | N/A |
| 9/30/2016 | 28 | 7 | N/A | 11 | N/A |
| 6/30/2016 | 28 | 6 | N/A | 11 | N/A |
| 3/31/2016 | 25 | 5 | N/A | 9 | N/A |
| 12/31/2015 | 23 | 5 | N/A | 8 | N/A |
| 9/30/2015 | 20 | 4 | N/A | 6 | N/A |
| 6/30/2015 | 17 | 3 | N/A | 4 | N/A |
| 3/31/2015 | 17 | 3 | N/A | 4 | N/A |
| 12/31/2014 | 17 | 3 | N/A | 4 | N/A |
| 9/30/2014 | 16 | 2 | N/A | 4 | N/A |
| 6/30/2014 | 14 | 2 | N/A | 4 | N/A |
| 12/31/2013 | 11 | 1 | N/A | 6 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: PME 'nin tahmini kazanç büyümesi (yıllık 19.1% ) tasarruf oranının ( 2.6% ) üzerindedir.
Kazançlar ve Piyasa: PME şirketinin kazançlarının (yıllık 19.1% ) Australian pazarından (yıllık 12.4% ) daha hızlı büyümesi öngörülüyor.
Yüksek Büyüme Kazançları: PME şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.
Gelir ve Pazar: PME şirketinin gelirinin (yıllık 17.1% ) Australian pazarından (yıllık 5.7% ) daha hızlı büyümesi öngörülüyor.
Yüksek Büyüme Geliri: PME şirketinin gelirinin (yıllık 17.1% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: PME 'nin Özsermaye Getirisi'nin 3 yıl içinde çok yüksek olması tahmin ediliyor ( 47.8 %).